On November 18, 2013 NeoGenomics, Inc. Announced that it entered into an exclusive alliance with Covance Central Laboratories to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials.
HUGE win!!!. Van Ortt and his team are delivering on the promise that research-based revenue stream WILL be a part of 2014 and a growing part of 2014. Great diversification with GREAT partner!
couldn't agree more......it may very well hit $7 at some point next year as targeted.... :D